WallStreetZenWallStreetZen

NASDAQ: TCBP
Tc Biopharm PLC Stock

$0.82-0.01 (-1.2%)
Updated Jul 12, 2024
TCBP Price
$0.82
Fair Value Price
N/A
Market Cap
$4.06M
52 Week Low
$0.72
52 Week High
$19.60
P/E
N/A
P/B
3x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
5.72
Operating Cash Flow
N/A
Beta
1.56
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TCBP Overview

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia, and ImmuniStim, an unmodified cell therapy to treat COVID-19. TC Biopharm was founded in 2013 and is headquartered in Motherwell, UK.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TCBP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TCBP is good value based on its book value relative to its share price (3x), compared to the US Biotechnology industry average (6.45x)
P/B vs Industry Valuation
TCBP's short-term liabilities ($5.95M) exceed its short-term assets ($5.25M)
Short-term Liabilities Financials
TCBP's short-term assets ($5.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more TCBP due diligence checks available for Premium users.

Be the first to know about important TCBP news, forecast changes, insider trades & much more!

TCBP News

Valuation

TCBP fair value

Fair Value of TCBP stock based on Discounted Cash Flow (DCF)
Price
$0.82
Fair Value
$2.72
Undervalued by
69.85%

TCBP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
-12.81x
Market
32.2x

TCBP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3x
Industry
6.45x
TCBP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TCBP's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.3M
Profit Margin
0%

Assets to liabilities

Assets
$9.3M
Liabilities
$7.9M
Debt to equity
5.72
TCBP's short-term liabilities ($5.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TCBP's short-term assets ($5.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TCBP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.1M
Investing
-$7.2k
Financing
$1.2M

TCBP vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TCBP$4.06M-1.20%N/A3.00x
TTNP$4.05M-9.69%-0.69x0.66x
TOVX$4.08M-2.88%-0.20x0.13x
GNPX$4.03M+4.35%-0.10x0.46x
ZVSA$4.09M-2.97%-0.00x0.36x

Tc Biopharm Stock FAQ

What is Tc Biopharm's quote symbol?

(NASDAQ: TCBP) Tc Biopharm trades on the NASDAQ under the ticker symbol TCBP. Tc Biopharm stock quotes can also be displayed as NASDAQ: TCBP.

If you're new to stock investing, here's how to buy Tc Biopharm stock.

What is the 52 week high and low for Tc Biopharm (NASDAQ: TCBP)?

(NASDAQ: TCBP) Tc Biopharm's 52-week high was $19.60, and its 52-week low was $0.72. It is currently -95.82% from its 52-week high and 13.73% from its 52-week low.

How much is Tc Biopharm stock worth today?

(NASDAQ: TCBP) Tc Biopharm currently has 98,902,641 outstanding shares. With Tc Biopharm stock trading at $0.82 per share, the total value of Tc Biopharm stock (market capitalization) is $4.06M.

Tc Biopharm stock was originally listed at a price of $2,120.00 in Feb 11, 2022. If you had invested in Tc Biopharm stock at $2,120.00, your return over the last 2 years would have been -99.96%, for an annualized return of -98.03% (not including any dividends or dividend reinvestments).

How much is Tc Biopharm's stock price per share?

(NASDAQ: TCBP) Tc Biopharm stock price per share is $0.82 today (as of Jul 12, 2024).

What is Tc Biopharm's Market Cap?

(NASDAQ: TCBP) Tc Biopharm's market cap is $4.06M, as of Jul 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Tc Biopharm's market cap is calculated by multiplying TCBP's current stock price of $0.82 by TCBP's total outstanding shares of 98,902,641.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.